Skip Navigation

European Journal of Heart Failure 2005 7(6):1027-1032; doi:10.1016/j.ejheart.2005.05.006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Theuns, D. A.M.J.
Right arrow Articles by Jordaens, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theuns, D. A.M.J.
Right arrow Articles by Jordaens, L. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: Differences between primary and secondary prophylaxis

Dominic A.M.J. Theuns*, Andrew S. Thornton, A. Peter J. Klootwijk, Marcoen F. Scholten, Pascal J.M.J. Vantrimpont, Aggie H.M.M. Balk and Luc J. Jordaens

Department of Cardiology Erasmus MC, Rotterdam, The Netherlands

* Corresponding author. Department of Electrophysiology, Bd416 P.O. Box 2040 3000 CA Rotterdam, The Netherlands. Tel.: +31 10 463 3991; fax: +31 10 463 4420. E-mail address: d.theuns{at}erasmusmc.nl


  Abstract

Background: The incidence of ventricular tachyarrhythmias in ICD patients with cardiac resynchronisation therapy (CRT-D) is not well studied.

Aim: To analyse event free survival in CRT-D patients with a primary or a secondary prophylactic ICD indication.

Methods: Prospective, single centre. Eighty-six patients, 44% with a primary prophylactic indication. Actuarial event-free rates for mortality and arrhythmias were calculated.

Results: Baseline clinical characteristics were not significantly different between primary and secondary prophylaxis. Primary prophylaxis patients were more likely to be in NYHA class III. Over 21 months, 724 ventricular events with therapy occurred in 36 patients (42%). The actuarial event-free rates, at 1 and 3 years, from appropriate ICD therapy were higher (P<0.001) for primary (79.0% and 67.8%) than for secondary prophylaxis (45.6% and 27.0%). Appropriate ICD therapy occurred more in NYHA class II compared to class III (P=0.016). Underlying disease (ischemic versus non-ischemic) and functional class did not play a role in multivariate analysis.

Conclusion: Important arrhythmic events in patients with heart failure, and CRT-D occur at a very high rate when the indication is secondary prophylaxis. Patients with primary prophylaxis have an annual event rate of 10%, even though they tend to have a worse heart failure class.

Key Words: Cardiac resynchronisation therapy • Heart failure • Defibrillation • ICD • Ventricular tachycardia

Received September 15, 2004; Revised February 6, 2005; Accepted May 10, 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe
Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review
JAMA, June 13, 2007; 297(22): 2502 - 2514.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.